Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | MicrobiomeTrials← Back to trialsNCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2018-10-08Est. Completion: 2028-12
Enrollment target: 411 participants Locations- HonorHealth Research Institute, Scottsdale, Arizona, United States
- Precision NextGen Oncology and Research, Beverly Hills, California, United States
- City of Hope, Duarte, California, United States
- Valkyrie Clinical Trials, Los Angeles, California, United States
- Children's Hospital of Orange County-Rady Children's Health, Orange, California, United States
- University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California, United States
- University of California, San Francisco (UCSF), San Francisco, California, United States
- Sarcoma Oncology Center, Santa Monica, California, United States
- University of Colorado Hospital, Aurora, Colorado, United States
- Emory University - Winship Cancer Institute, Atlanta, Georgia, United States
- The University of Chicago, Chicago, Illinois, United States
- University of Michigan, Ann Arbor, Michigan, United States
- START Midwest Michigan, PC, Grand Rapids, Michigan, United States
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States
Other microbiome trials you might be interested in
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt LymphomaNeuroblastomaEwing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United StatesEst. completion Mar 31, 2029
Ewing SarcomaOsteosarcomaSarcomas
The purpose of this study is to better understand how safe and effective the drug cabozantinib in combination with high-…
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United StatesCleveland Clinic, Cleveland, Ohio, United StatesOregon Health & Science University, Portland, Oregon, United StatesChildren's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia, Pennsylvania, United StatesUniversity of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United StatesVanderbilt University School of Medicine, Nashville, Tennessee, United StatesUT MD Anderson Cancer Center, Houston, Texas, United StatesNEXT Oncology, San Antonio, Texas, United StatesUniversity of Virginia, Charlottesville, Virginia, United StatesNEXT Oncology - Virginia, Fairfax, Virginia, United StatesCentre Leon Berard, Lyon, FranceGustave Roussy, Villejuif, FranceLa Fondazione e l'Istituto di Candiolo, Candiolo, ItalyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyUniversity Medical Center Groningen, Groningen, NetherlandsAcademisch Ziekenhuis Leiden, Leiden, NetherlandsHospital Universitario Vall d'Hebron, Barcelona, SpainHospital de la Santa Creu i Sant Pau, Barcelona, SpainHospital Clinico San Carlos, Madrid, SpainGreat North Children's Hospital, London, United KingdomUniversity College London Hospital, London, United KingdomThe Royal Marsden NHS Foundation Trust, London, United KingdomRoyal Manchester Children's Hospital, Manchester, United KingdomSan Francisco, United StatesEst. completion Nov 2027